- Home
- CRVS vs UNTY Comparison
CRVS vs UNTY Comparison
Compare CRVS & UNTY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRVS
- UNTY
- Stock Information
- Founded
- CRVS 2014
- UNTY 1991
- Country
- CRVS United States
- UNTY United States
- Employees
- CRVS N/A
- UNTY N/A
- Industry
- CRVS Biotechnology: Pharmaceutical Preparations
- UNTY Major Banks
- Sector
- CRVS Health Care
- UNTY Finance
- Exchange
- CRVS Nasdaq
- UNTY Nasdaq
- Market Cap
- CRVS 459.0M
- UNTY 507.4M
- IPO Year
- CRVS 2016
- UNTY 1997
- Fundamental
- Price
- CRVS $7.59
- UNTY $47.82
- Analyst Decision
- CRVS Strong Buy
- UNTY Buy
- Analyst Count
- CRVS 4
- UNTY 3
- Target Price
- CRVS $13.75
- UNTY $59.67
- AVG Volume (30 Days)
- CRVS 1.0M
- UNTY 48.0K
- Earning Date
- CRVS 11-04-2025
- UNTY 10-14-2025
- Dividend Yield
- CRVS N/A
- UNTY 1.25%
- EPS Growth
- CRVS N/A
- UNTY 35.12
- EPS
- CRVS N/A
- UNTY 5.27
- Revenue
- CRVS N/A
- UNTY $121,970,000.00
- Revenue This Year
- CRVS N/A
- UNTY $24.41
- Revenue Next Year
- CRVS N/A
- UNTY $11.16
- P/E Ratio
- CRVS N/A
- UNTY $9.07
- Revenue Growth
- CRVS N/A
- UNTY 20.98
- 52 Week Low
- CRVS $2.54
- UNTY $36.65
- 52 Week High
- CRVS $10.00
- UNTY $54.64
- Technical
- Relative Strength Index (RSI)
- CRVS 58.78
- UNTY 45.49
- Support Level
- CRVS $6.81
- UNTY $47.32
- Resistance Level
- CRVS $7.96
- UNTY $49.26
- Average True Range (ATR)
- CRVS 0.52
- UNTY 1.78
- MACD
- CRVS -0.03
- UNTY -0.02
- Stochastic Oscillator
- CRVS 67.50
- UNTY 39.63
About CRVS Corvus Pharmaceuticals Inc.
Corvus Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing product candidates that precisely target proteins that are critical to immune cell maturation and function. Its product candidate, soquelitinib, is designed to bind specifically to a protein, interleukin 2 inducible T cell kinase (ITK), involved in T cell activation, T cell receptor signaling and T cell differentiation and function. The other products include Ciforadenant (CPI-444) and Mupadolimab (CPI-006).
About UNTY Unity Bancorp Inc.
Unity Bancorp Inc is a bank holding company that serves as a holding company for Unity Bank. It conducts a traditional and community-oriented commercial banking business and offers services, including personal and business checking accounts, time deposits, money market accounts, regular savings accounts, and others. The company structures its specific services and charges in a manner designed to attract the business of small and medium-sized businesses and professional communities, as well as individuals residing, working, and shopping in its service area. The company engages in a wide range of lending activities and offers commercial, Small Business Administration, consumer, mortgage, home equity, and personal loans.